MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Noteworthy Wednesday Option Activity: VRAY, CLVS, DPLO
Wednesday, November 13, 3:16 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

The Implied Analyst 12-Month Target For UWM
Thursday, November 14, 7:55 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

First Week of July 2020 Options Trading For Clovis Oncology (CLVS)
Tuesday, November 19, 11:02 AM ET, by Market News Video Staff

Investors in Clovis Oncology Inc (CLVS) saw new options begin trading this week, for the ...

CLVS: Insiders vs. Shorts
Tuesday, November 19, 3:13 PM ET, by Market News Video Staff

The most recent short interest data was recently released for the 04/15/2019 settlement date, and ...

Noteworthy Wednesday Option Activity: DXCM, EXPE, CLVS
Wednesday, November 27, 3:29 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

Clovis Oncology Enters Oversold Territory (CLVS)

By Market News Video Staff, Monday, March 25, 4:21 PM ET
Play Video: Learn About The RSI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Monday, shares of Clovis Oncology Inc (NASDAQ:CLVS) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $22.95 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 54.0. A bullish investor could look at CLVS's 29.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of CLVS shares:

Clovis Oncology Inc 1 Year Performance Chart

Looking at the chart above, CLVS's low point in its 52 week range is $11.50 per share, with $65.24 as the 52 week high point that compares with a last trade of $23.04. Find out what 9 other oversold stocks you need to know about


Special Offer: Join the income investing conversation on ValueForum.com with a special Seven Days for Seven Dollars invitation.


This Article's Word Cloud:   About   Buffett   CLVS   Clovis   Days   Dollars   Find   Index   Join   Know   Legendary   Looking   Monday   Offer   Oncology   Oversold   Relative   Seven   Should   Special   Start   Stocks   Strength   ValueForum   Warren   about   above   advises   after   analysis   begin   below   bullish   called   chart   fearful   greedy   investor   look   others   oversold   point   reading   share   shares   stock   that   week   when   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

Clovis Oncology Enters Oversold Territory (CLVS) | Market News Video | Copyright © 2008 - 2020, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.